Allergan (AGN) Initiates Qtr. Dividend at 70c/Share; Approves $10B to Stock Buyback Plan
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Allergan (AGN) Misses Q3 EPS Views; Offers Pipeline, FY16 Guidance Updates
November 2, 2016 6:37 AM EDTAllergan (NYSE: AGN) reported Q3 EPS of $3.32, $0.26 worse than the analyst estimate of $3.58. Revenue for the quarter came in at $3.62 billion versus the consensus estimate of $3.69 billion.
New Dividend and Stock Buyback:
Allergan (NYSE: AGN) initiated a quarterly dividend of $0.70 per share, or $2.8 annualized. Yield is currently 1.3 percent.
Allergan also entered into a variable tenor accelerated share repurchase program (ASR) under which the Company will repurchase $10 billion of its ordinary shares.
Pipeline Update
Allergan R&D continued to build and deliver on... More